# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Phaseollin | 15 | INH | = | 0 | % | ALA4053426 | % | Homo sapiens | |||
2. | Phaseollin | 15 | INH | = | 6.8 | % | ALA4053425 | % | Homo sapiens | |||
3. | Phaseollin | 15 | INH | = | 34.7 | % | ALA4053424 | % | Homo sapiens | |||
4. | Phaseollin | 15 | INH | = | 0 | % | ALA4053423 | % | Homo sapiens | |||
5. | Phaseollin | 15 | INH | = | 2.1 | % | ALA4053420 | % | ||||
6. | Phaseollin | 15 | INH | = | 2.6 | % | ALA4053418 | % | Mus musculus | |||
7. | Phaseollin | 15 | FC | = | 1.5 | ALA4053417 | Homo sapiens | |||||
8. | Phaseollin | 15 | INH | = | 9.5 | % | ALA4053415 | % | Homo sapiens | |||
9. | Phaseollin | 15 | INH | = | 2.4 | % | ALA4053412 | % | Homo sapiens | |||
10. | Phaseollin | 15 | Activity | 0 | ALA5255946 | Dose-Dependent Effect | ||||||
11. | Phaseollin | 15 | GI50 | > | 100 | uM | ALA5255945 | nM | Homo sapiens | |||
12. | Phaseollin | 15 | GI50 | = | 4.65 | uM | ALA5255944 | nM | ||||
13. | Phaseollin | 15 | Activity | 0 | ALA1109003 | Dose-dependent effect | Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961) | |||||
14. | Phaseollin | 15 | Activity | 0 | ALA1108201 | Dose-dependent effect | Clostridium perfringens | |||||
15. | Phaseollin | 15 | INH | = | 9 | % | ALA1111888 | % | Clostridium perfringens | |||
16. | Phaseollin | 15 | INH | = | 91 | % | ALA1111887 | % | Clostridium perfringens | |||
17. | Phaseollin | 15 | INH | 0 | ALA1111892 | Active | % | Clostridium perfringens | ||||
18. | Phaseollin | 15 | INH | 0 | ALA1111890 | Active | % | Clostridium perfringens | ||||
19. | Phaseollin | 15 | INH | 0 | ALA1111886 | Active | % | Clostridium perfringens | ||||
20. | Phaseollin | 15 | INH | 0 | ALA1111885 | Active | % | Clostridium perfringens |